Myopia, commonly called nearsightedness, occurs when the eye grows too long from front to back. This causes distant objects to appear blurry while close-up vision remains clear. When myopia develops in childhood, it typically worsens as the eye continues to grow, often progressing until the late teens or early twenties.
At Insight Vision Center Optometry in Costa Mesa, we understand that watching your child's nearsightedness get worse year after year can be frustrating and concerning. Myopia management is a proactive approach that uses proven treatments to slow the progression of nearsightedness in young eyes, reducing the risk of serious eye health problems later in life.
Childhood myopia tends to worsen because young eyes are still growing and developing. Genetics play a significant role, especially if one or both parents are nearsighted. Environmental factors like prolonged near work, limited outdoor time, and extensive screen use can also contribute to progression. If you notice signs of vision difficulty, our children's symptom checker can help you identify whether your child may need evaluation.
As myopia becomes more severe, the eye stretches longer, causing the retina and other internal structures to thin. This stretching significantly increases the lifetime risk of sight-threatening conditions including retinal detachment, glaucoma, cataracts, and myopic maculopathy. Even moderate myopia carries elevated risks compared to normal vision.
Our goal is not to eliminate myopia entirely, but to slow its progression significantly. Published research shows that reducing myopia progression by even 30 to 50 percent can substantially lower the risk of developing high myopia and its associated complications. Starting treatment early, typically when myopia is first detected or progression is noted, tends to produce the best outcomes.
We provide multiple evidence-based myopia control treatments, each with unique benefits. Our eye doctors will recommend the most appropriate option based on your child's age, lifestyle, degree of myopia, and rate of progression. Some children benefit from combining two therapies for enhanced effectiveness.
Stellest lenses are the first FDA-approved eyeglasses specifically designed to slow myopia progression in children. These lenses feature a clear central zone for sharp vision surrounded by hundreds of tiny lenslets that create specific signals to slow eye growth. Clinical studies demonstrate that Stellest lenses can slow myopia progression by an average of 67 percent when worn at least 12 hours daily.
Our practice has deep experience with Stellest technology. Dr. Thanh Mai, OD, FSLS, FIAOMC serves on the EssilorLuxottica advisory board for Stellest and brings extensive experience fitting these lenses for children of all ages.
MiSight 1 Day are soft, daily disposable contact lenses approved by the FDA for myopia control in children ages 8 to 12 at the initiation of treatment. These lenses use dual-focus technology, with treatment zones that slow eye elongation while correction zones provide clear distance vision. Research shows MiSight lenses can reduce myopia progression by approximately 59 percent over three years.
Daily disposable lenses offer excellent safety and convenience since children insert a fresh, sterile lens each morning and discard it at night. This eliminates the need for lens cleaning and reduces infection risk.
Orthokeratology, often called ortho-k, involves wearing specially designed gas-permeable contact lenses overnight. These lenses gently reshape the cornea while your child sleeps, providing clear vision throughout the day without glasses or daytime contacts. Beyond vision correction, ortho-k has been shown to slow myopia progression by 30 to 60 percent in numerous studies.
Our practice offers advanced ortho-k fitting using the Euclid Phoenix lens design. Dr. Nathan Schramm, OD, FSLS, FBCLA served as principal investigator for the Euclid Phoenix randomized clinical trial and has presented multiple research findings on orthokeratology outcomes. Dr. Thanh Mai, OD, FSLS, FIAOMC and Dr. Ariel Chen, OD also bring extensive ortho-k experience to our team.
Low-dose atropine eye drops have demonstrated significant effectiveness in slowing myopia progression. Unlike the high-concentration atropine used for other eye conditions, myopia control protocols use very dilute concentrations, typically 0.01 to 0.05 percent. These low doses minimize side effects like light sensitivity and near vision blur while maintaining myopia control benefits.
Atropine is often used as a standalone treatment or combined with optical interventions like orthokeratology or multifocal contact lenses for enhanced control. Our optometrists carefully customize atropine protocols based on each child's progression pattern and treatment response.
We fit various multifocal soft contact lens designs that provide clear central vision while incorporating peripheral defocus to slow eye growth. Options include center-distance and extended-depth-of-focus designs in both daily and monthly replacement schedules. These lenses work well for children and teens who prefer daytime contact lens wear.
Effective myopia management requires accurate measurement and consistent monitoring. We use advanced diagnostic equipment to track not just prescription changes, but actual eye growth and structure. This allows us to assess treatment effectiveness objectively and adjust protocols as needed.
The Zeiss AXL WAVE Optical Biometer measures axial length, which is the front-to-back length of the eye. Since myopia progression results from excessive axial elongation, tracking this measurement provides the most accurate assessment of whether treatment is controlling eye growth. We measure axial length at baseline and regular follow-up visits to quantify treatment success.
This non-invasive measurement takes only seconds and is completely comfortable for children.
We utilize Pentacam imaging and the Tomey WaveDyn Aberrometer to create detailed maps of corneal shape and measure optical aberrations. These technologies are particularly important for orthokeratology fitting and monitoring, ensuring lenses achieve optimal corneal reshaping. The devices also help us detect subtle corneal changes and assess overall eye health.
Each myopia management visit includes thorough evaluation of eye health, visual function, and treatment compliance. We check for any adverse effects, assess lens fit and comfort, measure visual acuity, and examine the retina and optic nerve. Our kid-friendly exam room and optometrists make each visit comfortable and efficient.
We are affiliated with Treehouse Eyes, a specialized myopia management network that provides structured protocols, enhanced education, and coordinated care. This program offers families access to comprehensive myopia education, coordinated treatment plans, and consistent monitoring schedules. Dr. Thanh Mai, OD, FSLS, FIAOMC serves as Vice President of Clinical Innovation for Treehouse Eyes, bringing advanced protocols directly to our patients.
Treatment can begin as soon as myopia is detected and progression is documented or anticipated based on age and risk factors. Many children start between ages 6 and 12, when myopia often progresses most rapidly. However, teenagers who continue to show progression also benefit from treatment. Earlier intervention typically provides better long-term outcomes because it allows more years of controlled growth during the critical development period.
We monitor treatment effectiveness through regular axial length measurements and prescription checks, typically every six months. Successful treatment shows minimal or no axial length growth compared to expected progression without intervention. We compare your child's measurements to established norms for age and baseline myopia level. If progression continues despite treatment, we can adjust the approach, increase treatment intensity, or try combination therapy.
Research indicates that stopping myopia control treatment before the eyes naturally stabilize often results in resumed progression, sometimes at rates similar to pre-treatment levels. We generally recommend continuing treatment through the mid-to-late teenage years when myopia typically stabilizes. Each child is different, so we monitor progression patterns carefully and discuss the appropriate duration based on age, stability, and individual risk factors.
Yes, myopia control treatments can benefit children with moderate to high myopia by preventing further worsening. While we cannot reverse existing myopia, slowing progression from high to very high levels still provides meaningful risk reduction. Every diopter of progression prevented helps protect long-term eye health.
Each FDA-approved or well-researched treatment option shows significant efficacy in clinical studies, but individual response varies. The best choice depends on your child's age, maturity, lifestyle, degree of myopia, rate of progression, and family preferences. Our optometrists evaluate multiple factors and discuss the pros and cons of each option to help you make an informed decision for your family.
Coverage varies significantly by insurance plan. Some vision plans now include myopia management benefits, while others may cover portions like comprehensive eye exams or contact lens fittings but not the specialized devices or therapies. Medical insurance occasionally covers atropine prescriptions. We recommend contacting your insurance carrier to understand your specific benefits, and our staff can provide detailed documentation to support coverage requests or reimbursement submissions.
Our fellowship-trained optometrists bring advanced credentials and focused experience in pediatric myopia management to Orange County families. We offer all major treatment options, advanced diagnostic technology, and personalized care plans tailored to each child's unique needs.
Whether you are just learning about myopia control or seeking a second opinion on treatment options, we welcome the opportunity to help protect your child's vision and long-term eye health.
